Black Rock Inc. Bio Path Holdings Inc Transaction History

Black Rock Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$0.36 - $0.75 $2,246 - $4,680	6,240 Added 12.87%	54,709 $25,000
Q2 2022 Aug 12, 2022	SELL	$2.83 - $4.02 $47,351 - $67,262	-16,732 Reduced 25.66%	48,469 $188,000
Q1 2022 May 12, 2022	SELL	$2.99 - $4.17 $2,421 - $3,377	-810 Reduced 1.23%	65,201 $250,000
Q4 2021 Feb 10, 2022	SELL	$3.77 - $5.24 $6,518 - $9,059	-1,729 Reduced 2.55%	66,011 $249,000
Q3 2021 Nov 09, 2021	SELL	$5.13 - $6.78 $2,154 - $2,847	-420 Reduced 0.62%	67,740 $348,000
Q2 2021 Aug 11, 2021	BUY	$5.13 - $7.63 $349,660 - $520,060	68,160 New	68,160 $454,000

Ticker BPTH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,160,160
Market Cap $5.51M
Description
Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nano particle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.